| abstract |
A compound selected from the group consisting of: ** Formula ** for use in a method for the treatment of a disease selected from a group consisting of cardiac hypertrophy, heart disease, transplant rejection, autoimmune diseases, immune deficiency , autism and inflammation, wherein said method comprises administering a pharmaceutically effective amount of said compound to a patient. |